Transdermal delivery using a novel electrochemical device, Part 1: Device design and in vitro release/permeation of fentanyl

被引:7
作者
Schroeder, Britta [3 ]
Nickel, Ulrich [2 ]
Meyer, Elisabeth [3 ]
Lee, Geoffrey [1 ]
机构
[1] Univ Erlangen Nurnberg, Div Pharmaceut, D-91077 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Div Phys Chem, D-91077 Erlangen, Germany
[3] Acino AG, D-83714 Miesbach, Germany
关键词
controlled release; diffusion; fentanyl; iontophoresis; skin; transdermal system; electrochemistry; flux enhancement; NARCOTIC ANALGESICS; STRATUM-CORNEUM; DRUG-DELIVERY; IONTOPHORESIS; BEHAVIOR;
D O I
10.1002/jps.22765
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new type of electrochemical transdermal patch has been investigated using release/permeation experiments with excised nude mouse skin. The patch comprises a drug-containing hydrogel sandwiched between two electrodes that are arranged parallel to the skin surface. The objective was to determine the mechanism of working of enhanced flux for the drug fentanyl when low voltages are applied. The results indicate that a voltage-induced hydrolysis of the water present in the patch's hydrogel occurs. This causes a pH shift that results in deprotonization of the fentanyl and hence enhanced release/permeation. The enhanced flux is up to approximately 30 mu g/(cm2 h) over 20h and requires only a low-voltage application over a duration of just 60s. Because the enhancement mechanism occurs in the patch and not in the skin, the potential for substantially reduced skin irritation compared with iontophoresis is given. (c) 2011 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 101:245255, 2012
引用
收藏
页码:245 / 255
页数:11
相关论文
共 20 条
[1]   An iontophoretic, fentanyl HCl patient-controlled transdermal system for acute postoperative pain management [J].
Chelly, JE .
EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (07) :1205-1214
[2]   Techniques of opioid administration [J].
Comerford, Dee .
ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2008, 9 (01) :21-26
[3]   Electrically modulated transdermal delivery of fentanyl [J].
Conjeevaram, R ;
Banga, AK ;
Zhang, L .
PHARMACEUTICAL RESEARCH, 2002, 19 (04) :440-444
[4]  
Corish J, 1992, Patent, Patent No. [U55533995, 5533995]
[5]  
Cussler E, 1997, DIFFUSION MASS TRANS, P143
[6]  
Dixit Nitin, 2007, Current Drug Delivery, V4, P1, DOI 10.2174/156720107779314802
[7]  
Fischer W, 2000, Patent, Patent No. [U56757560, 6757560]
[8]   MEASUREMENT OF DRUG DIFFUSIVITY IN STRATUM-CORNEUM MEMBRANES AND A POLYACRYLATE MATRIX [J].
GOPFERICH, A ;
LEE, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 71 (03) :245-253
[9]   Clinical pharmacokinetics of transdermal opioids - Focus on transdermal fentanyl [J].
Grond, S ;
Radbruch, L ;
Lehmann, KA .
CLINICAL PHARMACOKINETICS, 2000, 38 (01) :59-89
[10]   Iontophoretic transport across the skin [J].
Guy, RH ;
Delgado-Charro, MB ;
Kalia, YN .
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2001, 14 :35-40